900161-13-9 Usage
Uses
Used in Pharmaceutical Industry:
(1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid is used as a potential pharmaceutical agent for its distinct molecular structure and pharmacological properties. (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid's unique arrangement of functional groups may contribute to its interaction with biological targets, offering a foundation for the development of new drugs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid serves as a subject of study for understanding its potential therapeutic effects and mechanisms of action. (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid's structural features may provide insights into the design of novel therapeutic agents with improved efficacy and selectivity.
Further research and testing are essential to fully explore the compound's potential uses and effects, as its complex structure and functional groups may offer novel avenues for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 900161-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,6 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 900161-13:
(8*9)+(7*0)+(6*0)+(5*1)+(4*6)+(3*1)+(2*1)+(1*3)=109
109 % 10 = 9
So 900161-13-9 is a valid CAS Registry Number.
900161-13-9Relevant academic research and scientific papers
Thrombin Receptor Antagonists Based On The Modified Tricyclic Unit Of Himbacine
-
Page/Page column 32, (2008/06/13)
Multiple stereoisomers of the heterocyclic-substituted tricyclics of the formula: or a pharmaceutically acceptable salt, solvate, or ester of said compound wherein R and the stereochemistry are illustrated in the structural formulas herein are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.
EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS
-
Page/Page column 43-44, (2008/06/13)
The application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The chemistry taught her
SYNTHESIS OF HIMBACINE ANALOGS
-
Page/Page column 29-30, (2008/06/13)
The present invention relates to an improved process for preparing imbacine analogs. The compounds are useful as thrombin receptor antagonists. The improved process may allow for at least one of easier purification by crystallization, easier scalability,
